Editorial Type:
Article Category: Other
 | 
Online Publication Date: Jan 01, 2017

Anesthetic Considerations for Patients on Antidepressant Therapy—Part I

DMD,
MD, and
DMD, MS, PhD
Page Range: 253 – 261
Save
Download PDF

Millions of patients take antidepressant medications in the United States for the treatment of depression or anxiety disorders. Some antidepressants are prescribed off-label to treat problems such as chronic pain, low energy, and menstrual symptoms. Antidepressants are a broad and expansive group of medications, but the more common drug classes include tricyclic antidepressants, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and monoamine oxidase inhibitors. A miscellaneous or “atypical” category covers other agents. Some herbal supplements that claim to have antidepressant activity will also be discussed. In Part I of this review, antidepressant pharmacology, adverse effects, and drug interactions with adrenergic agonists will be discussed. In part II, drug interactions with sedation and general anesthetics will be reviewed. Bleeding effects and serotonin syndrome implications in anesthetic practice will also be highlighted.

  • Download PDF
Copyright: © 2017 by the American Dental Society of Anesthesiology
<bold>Figure 1. </bold>
Figure 1. 

Antidepressant medications within the 4 therapeutic drug classes.


<bold>Figure 2. </bold>
Figure 2. 

Vasoconstrictor interaction with tricyclic antidepressants and serotonin-norepinephrine reuptake inhibitors.


<bold>Figure 3. </bold>
Figure 3. 

(A) Naïve nerve terminal. (B) Nerve terminal plus a monoamine oxidase inhibitor. (C) Nerve terminal with epinephrine. (D) Nerve terminal with ephedrine.


<bold>Figure 4. </bold>
Figure 4. 

Lack of vasoconstrictor interaction with selective serotonin reuptake inhibitors.


Contributor Notes

Address correspondence to Dr Mana Saraghi, Jacobi Medical Center, 1400 Pelham Parkway South, Bldg 1, Suite 3NE1, Bronx, NY 10461; msaraghi@gmail.com.
Received: Sep 13, 2017
Accepted: Sep 13, 2017